Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Parkinsonism Relat Disord. 2020 Nov 26;82:98–103. doi: 10.1016/j.parkreldis.2020.11.020

Table 4.

Significant pathways based on the 289 features associated with CD at p<0.05 in MWAS.

Pathways Overlap size Pathway size P-value
Prostaglandin formation from dihomo gama-linoleic acid 3 5 <.001
Pentose phosphate pathway 4 22 0.005
Arachidonic acid metabolism 3 17 0.013
Leukotriene metabolism 3 18 0.015
Starch and Sucrose Metabolism 2 10 0.030
Valine, leucine and isoleucine degradation 3 23 0.031
Galactose metabolism 3 23 0.031
Fructose and mannose metabolism 2 14 0.047
Propanoate metabolism 2 14 0.047